Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 460

1.

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.

Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA.

Int J Cardiol. 2018 May 1;258:185-191. doi: 10.1016/j.ijcard.2018.01.067.

PMID:
29544928
2.

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.

Cerbin LP, Ambrosy AP, Greene SJ, Armstrong PW, Butler J, Coles A, DeVore AD, Ezekowitz JA, Hernandez AF, Metra M, Starling RC, Tang W, Teerlink JR, Voors AA, Wu A, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2018 Apr;6(4):298-307. doi: 10.1016/j.jchf.2018.01.018. Epub 2018 Mar 7.

PMID:
29525328
3.

Risk stratification in acute heart failure: reply.

Demissei BG, Voors AA.

Eur J Heart Fail. 2018 Mar 7. doi: 10.1002/ejhf.1171. [Epub ahead of print] No abstract available.

PMID:
29512236
4.

Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL? Reply.

Ng LL, Voors AA.

Eur J Heart Fail. 2018 Mar 2. doi: 10.1002/ejhf.1173. [Epub ahead of print] No abstract available.

PMID:
29498159
5.

Sense and Sensibility of the Use of NT-proBNP for Eligibility in Clinical Trials.

Voors AA.

JACC Heart Fail. 2018 Mar;6(3):257-259. doi: 10.1016/j.jchf.2018.01.003. Epub 2018 Feb 7. No abstract available.

PMID:
29428436
6.

Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.

Ouwerkerk W, Zwinderman AH, Ng LL, Demissei B, Hillege HL, Zannad F, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Ter Maaten JM, Lang CC, van der Harst P, Filippatos G, Dickstein K, Cleland JG, Anker SD, Voors AA.

J Am Coll Cardiol. 2018 Jan 30;71(4):386-398. doi: 10.1016/j.jacc.2017.11.041.

PMID:
29389354
7.

Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.

Grote Beverborg N, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH, Swinkels DW, van Pelt J, Mulder AB, Bulstra SK, Vellenga E, Mariani MA, de Boer RA, van Veldhuisen DJ, van der Meer P.

Circ Heart Fail. 2018 Feb;11(2):e004519. doi: 10.1161/CIRCHEARTFAILURE.117.004519.

PMID:
29382661
8.

N-terminal pro-B-type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure.

Tromp J, Richards AM, Tay WT, Teng TK, Yeo PSD, Sim D, Jaufeerally F, Leong G, Ong HY, Ling LH, van Veldhuisen DJ, Jaarsma T, Voors AA, van der Meer P, de Boer RA, Lam CSP.

ESC Heart Fail. 2018 Apr;5(2):279-287. doi: 10.1002/ehf2.12252. Epub 2018 Jan 30.

9.

Heart failure with mid-range ejection fraction: causes and consequences.

Tromp J, Voors AA, Lam CSP.

Eur J Heart Fail. 2018 Apr;20(4):660-662. doi: 10.1002/ejhf.1134. Epub 2018 Jan 16. No abstract available.

PMID:
29336093
10.

Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.

Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Rossignol P, Zannad F, Voors AA, van der Meer P.

Eur J Heart Fail. 2018 Jan 12. doi: 10.1002/ejhf.1079. [Epub ahead of print]

PMID:
29327797
11.

Diabetes Mellitus and Right Ventricular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Gorter TM, Streng KW, van Melle JP, Rienstra M, Dickinson MG, Lam CSP, Hummel YM, Voors AA, Hoendermis ES, van Veldhuisen DJ.

Am J Cardiol. 2018 Mar 1;121(5):621-627. doi: 10.1016/j.amjcard.2017.11.040. Epub 2017 Dec 11.

PMID:
29307460
12.

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.

Metra M, Davison BA, Gimpelewicz C, Carubelli V, Felker GM, Filippatos G, Greenberg BH, Hua TA, Liu Z, Pang PS, Ponikowski P, Severin TM, Voors AA, Wang Y, Cotter G, Teerlink JR.

Int J Cardiol. 2018 Feb 15;253:91-96. doi: 10.1016/j.ijcard.2017.09.185.

PMID:
29306479
13.

Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.

Ter Maaten JM, Voors AA, Damman K, van der Meer P, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Navis G, Ng L, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, de Borst MH.

Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010.

PMID:
29306478
14.

Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.

Pokorney SD, Al-Khatib SM, Sun JL, Schulte P, O'Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ.

Eur J Heart Fail. 2018 Mar;20(3):525-532. doi: 10.1002/ejhf.1078. Epub 2017 Dec 20.

PMID:
29266564
15.

Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients.

Petrie CJ, Ponikowski P, Metra M, Mitrovic V, Ruda M, Fernandez A, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Voors AA.

Clin Exp Hypertens. 2017 Dec 21:1-7. doi: 10.1080/10641963.2017.1416121. [Epub ahead of print]

PMID:
29265934
16.

Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.

Emmens JE, Jones DJL, Cao TH, Chan DCS, Romaine SPR, Quinn PA, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, de Boer RA, Voors AA, Ng LL.

Eur J Heart Fail. 2018 Feb;20(2):260-267. doi: 10.1002/ejhf.1101. Epub 2017 Dec 18.

PMID:
29251807
17.

Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation.

Gorter TM, van Melle JP, Rienstra M, Borlaug BA, Hummel YM, van Gelder IC, Hoendermis ES, Voors AA, van Veldhuisen DJ, Lam CSP.

J Card Fail. 2018 Mar;24(3):177-185. doi: 10.1016/j.cardfail.2017.11.005. Epub 2017 Nov 29.

18.

Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.

van der Pol A, Gil A, Silljé HHW, Tromp J, Ovchinnikova ES, Vreeswijk-Baudoin I, Hoes M, Domian IJ, van de Sluis B, van Deursen JM, Voors AA, van Veldhuisen DJ, van Gilst WH, Berezikov E, van der Harst P, de Boer RA, Bischoff R, van der Meer P.

Sci Transl Med. 2017 Nov 8;9(415). pii: eaam8574. doi: 10.1126/scitranslmed.aam8574.

PMID:
29118264
19.

Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with 13N-NH3 positron emission tomography and echocardiography.

Assa S, Kuipers J, Ettema E, Gaillard CAJM, Krijnen WP, Hummel YM, Voors AA, van Melle JP, Westerhuis R, Willemsen A, Slart RHJA, Franssen CFM.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F445-F452. doi: 10.1152/ajprenal.00368.2017. Epub 2017 Nov 8.

PMID:
29117996
20.

Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

Fudim M, O'Connor CM, Dunning A, Ambrosy AP, Armstrong PW, Coles A, Ezekowitz JA, Greene SJ, Metra M, Starling RC, Voors AA, Hernandez AF, Michael Felker G, Mentz RJ.

Eur J Heart Fail. 2018 Feb;20(2):304-314. doi: 10.1002/ejhf.1020. Epub 2017 Oct 29.

PMID:
29082629
21.

What have we learned about heart failure with mid-range ejection fraction one year after its introduction?

Nauta JF, Hummel YM, van Melle JP, van der Meer P, Lam CSP, Ponikowski P, Voors AA.

Eur J Heart Fail. 2017 Dec;19(12):1569-1573. doi: 10.1002/ejhf.1058. Epub 2017 Oct 24. Review.

PMID:
29067761
22.

The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.

Bayes-Genis A, Núñez J, Zannad F, Ferreira JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Metra M, Lupón J, Voors AA.

J Am Coll Cardiol. 2017 Oct 24;70(17):2128-2136. doi: 10.1016/j.jacc.2017.08.057.

23.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.

Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski P, Temple T, Pieske B, Ezekowitz J, Hernandez AF, Koglin J, O'Connor CM.

JACC Heart Fail. 2018 Feb;6(2):96-104. doi: 10.1016/j.jchf.2017.08.013. Epub 2017 Oct 11. Review.

24.

Prevalence and predictive value of electrocardiographic abnormalities in pulmonary hypertension: evidence from the Pan-African Pulmonary Hypertension Cohort (PAPUCO) study.

Balieva I, Dzudie A, Thienemann F, Mocumbi AO, Karaye K, Sani MU, Ogah OS, Voors AA, Kengne AP, Sliwa K.

Cardiovasc J Afr. 2017 Nov/Dec 23;28(6):370-376. doi: 10.5830/CVJA-2017-020. Epub 2017 Oct 11.

25.

Lessons Learned and to Be Learned About the Use of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure and Atrial Fibrillation.

Voors AA, Lam CSP.

Circ Heart Fail. 2017 Oct;10(10). pii: e004552. doi: 10.1161/CIRCHEARTFAILURE.117.004552. No abstract available.

PMID:
29018175
26.

Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Cotter G, Davison BA, Butler J, Collins SP, Ezekowitz JA, Felker GM, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Senger S, Bharucha D, Goin K, Soergel DG, Pang PS.

Clin Res Cardiol. 2018 Feb;107(2):170-181. doi: 10.1007/s00392-017-1168-0. Epub 2017 Oct 6.

PMID:
28986703
27.

Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.

Hummel YM, Liu LCY, Lam CSP, Fonseca-Munoz DF, Damman K, Rienstra M, van der Meer P, Rosenkranz S, van Veldhuisen DJ, Voors AA, Hoendermis ES.

Eur J Heart Fail. 2017 Dec;19(12):1651-1660. doi: 10.1002/ejhf.957. Epub 2017 Oct 6.

PMID:
28984057
28.

Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.

van Boven N, Kardys I, van Vark LC, Akkerhuis KM, de Ronde MWJ, Khan MAF, Merkus D, Liu Z, Voors AA, Asselbergs FW, van den Bos EJ, Boersma E, Hillege H, Duncker DJ, Pinto YM, Postmus D.

Eur J Heart Fail. 2018 Jan;20(1):89-96. doi: 10.1002/ejhf.950. Epub 2017 Sep 25.

PMID:
28948688
29.

Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure.

Dickinson MG, Lam CS, Rienstra M, Vonck TE, Hummel YM, Voors AA, Hoendermis ES.

Eur J Heart Fail. 2017 Nov;19(11):1483-1490. doi: 10.1002/ejhf.959. Epub 2017 Sep 25.

PMID:
28948687
30.

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.

Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR.

Am Heart J. 2017 Aug;190:113-122. doi: 10.1016/j.ahj.2017.05.012. Epub 2017 May 27.

31.

Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR.

Clin Res Cardiol. 2017 Nov;106(11):938. doi: 10.1007/s00392-017-1139-5. No abstract available.

PMID:
28752374
32.

Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO2 Slope in Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension.

Klaassen SHC, Liu LCY, Hummel YM, Damman K, van der Meer P, Voors AA, Hoendermis ES, van Veldhuisen DJ.

J Card Fail. 2017 Nov;23(11):777-782. doi: 10.1016/j.cardfail.2017.07.397. Epub 2017 Jul 20.

33.

Atrial Fibrillation in Heart Failure: A Common and Deadly Combination.

Lam CSP, Santema BT, Voors AA.

JACC Heart Fail. 2017 Aug;5(8):575-577. doi: 10.1016/j.jchf.2017.05.010. Epub 2017 Jul 12. No abstract available.

PMID:
28711450
34.

The Fastest Way to the Failing Heart Is Through the Kidneys.

Damman K, Voors AA.

JACC Heart Fail. 2017 Sep;5(9):682-683. doi: 10.1016/j.jchf.2017.06.001. Epub 2017 Jul 12. No abstract available.

PMID:
28711445
35.

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.

van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Böhm M, Doletsky A, Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A; EFFECT-HF Investigators.

Circulation. 2017 Oct 10;136(15):1374-1383. doi: 10.1161/CIRCULATIONAHA.117.027497. Epub 2017 Jul 12.

36.

Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure.

Damman K, Valente MAE, van Veldhuisen DJ, Cleland JGF, O'Connor CM, Metra M, Ponikowski P, Cotter G, Davison B, Givertz MM, Bloomfield DM, Hillege HL, Voors AA.

Int J Mol Sci. 2017 Jul 8;18(7). pii: E1470. doi: 10.3390/ijms18071470.

37.

Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.

Liu LCY, Valente MAE, Postmus D, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Hillege HL, van der Meer P, Voors AA.

Cardiovasc Drugs Ther. 2017 Jun;31(3):281-293. doi: 10.1007/s10557-017-6726-1.

38.

Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.

Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T.

J Am Coll Cardiol. 2017 Jun 27;69(25):3042-3051. doi: 10.1016/j.jacc.2017.04.042.

PMID:
28641794
39.

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.

Greene SJ, Hernandez AF, Dunning A, Ambrosy AP, Armstrong PW, Butler J, Cerbin LP, Coles A, Ezekowitz JA, Metra M, Starling RC, Teerlink JR, Voors AA, O'Connor CM, Mentz RJ.

J Am Coll Cardiol. 2017 Jun 27;69(25):3029-3039. doi: 10.1016/j.jacc.2017.04.043.

PMID:
28641792
40.

A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure.

Sharma A, Demissei BG, Tromp J, Hillege HL, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, van Veldhuisen DJ, Cotter G, Ezekowitz JA, Khan MAF, Voors AA.

Eur J Heart Fail. 2017 Oct;19(10):1310-1320. doi: 10.1002/ejhf.912. Epub 2017 Jun 21.

41.

Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.

Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P.

JACC Heart Fail. 2017 Jul;5(7):507-517. doi: 10.1016/j.jchf.2017.04.007. Epub 2017 Jun 14.

42.

Clinical and prognostic value of spot urinary creatinine in chronic heart failure-An analysis from GISSI-HF.

Ter Maaten JM, Maggioni AP, Latini R, Masson S, Tognoni G, Tavazzi L, Signorini S, Voors AA, Damman K.

Am Heart J. 2017 Jun;188:189-195. doi: 10.1016/j.ahj.2017.01.017. Epub 2017 Apr 4.

PMID:
28577676
43.

Associations between volume status and circulating microRNAs in acute heart failure.

Vegter EL, van der Meer P, Voors AA.

Eur J Heart Fail. 2017 Aug;19(8):1077-1078. doi: 10.1002/ejhf.867. Epub 2017 May 25. No abstract available.

PMID:
28547885
44.

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.

Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, van der Meer P, Damman K, Voors AA, Goldsmith SR.

Clin Res Cardiol. 2017 Oct;106(10):802-812. doi: 10.1007/s00392-017-1122-1. Epub 2017 May 24.

45.

Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.

Gorter TM, van Veldhuisen DJ, Voors AA, Hummel YM, Lam CSP, Berger RMF, van Melle JP, Hoendermis ES.

Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):425-432. doi: 10.1093/ehjci/jex133.

PMID:
28531295
46.

Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure.

Moliner P, Jankowska EA, van Veldhuisen DJ, Farre N, Rozentryt P, Enjuanes C, Polonski L, Meroño O, Voors AA, Ponikowski P, Van der Meer P, Comin-Colet J.

Int J Cardiol. 2017 Sep 15;243:360-366. doi: 10.1016/j.ijcard.2017.04.110. Epub 2017 May 3.

PMID:
28511855
47.

Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research.

Costanzo MR, Ronco C, Abraham WT, Agostoni P, Barasch J, Fonarow GC, Gottlieb SS, Jaski BE, Kazory A, Levin AP, Levin HR, Marenzi G, Mullens W, Negoianu D, Redfield MM, Tang WHW, Testani JM, Voors AA.

J Am Coll Cardiol. 2017 May 16;69(19):2428-2445. doi: 10.1016/j.jacc.2017.03.528. Review.

48.

Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.

Vegter EL, Ovchinnikova ES, Silljé HHW, Meems LMG, van der Pol A, van der Velde AR, Berezikov E, Voors AA, de Boer RA, van der Meer P.

PLoS One. 2017 May 5;12(5):e0177242. doi: 10.1371/journal.pone.0177242. eCollection 2017.

49.

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.

Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, Voors AA, Dominjon F, Henon-Goburdhun C, Pannaux M, Böhm M; prEserveD left ventricular ejectIon fraction chronic heart Failure with ivabradine studY (EDIFY) Investigators.

Eur J Heart Fail. 2017 Nov;19(11):1495-1503. doi: 10.1002/ejhf.876. Epub 2017 Apr 30.

PMID:
28462519
50.

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).

Pang PS, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Bharucha D, Goin K, Soergel DG, Felker GM.

Eur Heart J. 2017 Aug 7;38(30):2364-2373. doi: 10.1093/eurheartj/ehx196.

PMID:
28459958

Supplemental Content

Loading ...
Support Center